M
Mélanie Drolet
Researcher at Laval University
Publications - 77
Citations - 6314
Mélanie Drolet is an academic researcher from Laval University. The author has contributed to research in topics: Vaccination & Population. The author has an hindex of 37, co-authored 74 publications receiving 5089 citations. Previous affiliations of Mélanie Drolet include Centers for Disease Control and Prevention & Université du Québec.
Papers
More filters
Journal ArticleDOI
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes : updated systematic review and meta-analysis
Mélanie Drolet,Élodie Bénard,Norma Pérez,Marc Brisson,Marc Brisson,Hammad Ali,Marie-Claude Boily,Vincenzo Baldo,Paul Brassard,Julia M.L. Brotherton,Denton Callander,Marta Checchi,Eric P F Chow,Silvia Cocchio,Tina Dalianis,Shelley L Deeks,Christian Dehlendorff,Basil Donovan,Christopher K Fairley,Elaine W. Flagg,Julia W Gargano,Suzanne M. Garland,Nathalie Grün,Bo T. Hansen,Christopher Harrison,Eva Herweijer,Teresa M. Imburgia,Anne M Johnson,Jessica A. Kahn,Kimberley Kavanagh,Susanne K. Kjaer,Erich V. Kliewer,Bette Liu,Dorothy A Machalek,Lauri E. Markowitz,David Mesher,Christian Munk,Linda M. Niccolai,Mari Nygård,Gina Ogilvie,Jeannie Oliphant,Kevin G.J. Pollock,Maria Jesús Purriños-Hermida,Megan Smith,Marc Steben,Anna Söderlund-Strand,Pam Sonnenberg,Pär Sparén,Clare Tanton,Cosette M. Wheeler,Petra J Woestenberg,Bo Nancy Yu +51 more
TL;DR: The results show compelling evidence of the substantial impact of HPV vaccination programmes on HPV infections and CIN2+ among girls and women, and on anogenital warts diagnoses among girls, women, boys, and men.
Journal ArticleDOI
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
Mélanie Drolet,Élodie Bénard,Marie-Claude Boily,Marie-Claude Boily,Hammad Ali,Louise Baandrup,Heidi M. Bauer,Simon Beddows,Jacques Brisson,Julia M.L. Brotherton,Teresa Cummings,Basil Donovan,Christopher K Fairley,Elaine W. Flagg,Anne M Johnson,Jessica A. Kahn,Kimberley Kavanagh,Susanne K. Kjaer,Erich V. Kliewer,Philippe Lemieux-Mellouki,Lauri E. Markowitz,Aminata Mboup,David Mesher,Linda M. Niccolai,Jeannie Oliphant,Kevin G.J. Pollock,Kate Soldan,Pam Sonnenberg,Sepehr N. Tabrizi,Sepehr N. Tabrizi,Clare Tanton,Marc Brisson,Marc Brisson +32 more
TL;DR: The results are promising for the long-term population-level effects of HPV vaccination programmes, however, continued monitoring is essential to identify any signals of potential waning efficacy or type-replacement.
Journal ArticleDOI
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
Talía Malagón,Mélanie Drolet,Marie-Claude Boily,Eduardo L. Franco,Mark Jit,Mark Jit,Jacques Brisson,Marc Brisson +7 more
TL;DR: The bivalent vaccine seems more efficacious against non-vaccine HPV types 31, 33, and 45 than the quadrivalent vaccine, but the differences were not all significant and might be attributable to differences in trial design.
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
Mélanie Drolet,Élodie Bénard,Marie-Claude Boily,Hammad Ali,Louise Baandrup,Simon Beddows,Jacques Brisson,Julia M.L. Brotherton,Teresa Cummings,Basil Donovan,Christopher K Fairley,Elaine W. Flagg,Anne M Johnson,Jessica A. Kahn,Kimberley Kavanagh,Susanne K. Kjaer,Erich V. Kliewer,Philippe Lemieux-Mellouki,Lauri E. Markowitz,Aminata Mboup,David Mesher,Linda M. Niccolai,Jeannie Oliphant,Kevin G.J. Pollock,Kate Soldan,Pam Sonnenberg,Sepehr N. Tabrizi,Clare Tanton,Marc Brisson +28 more
TL;DR: A systematic review and meta-analysis to assess the population-level consequences and herd effects after female HPV vaccination programs, to verify whether or not the high efficacy reported in randomised controlled clinical trials are materialising in real-world situations is materializing in realworld situations.
Journal ArticleDOI
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Marc Brisson,Marc Brisson,Jane J. Kim,Karen Canfell,Karen Canfell,Karen Canfell,Mélanie Drolet,Guillaume Gingras,Emily A. Burger,Emily A. Burger,Dave Martin,Kate T. Simms,Kate T. Simms,Élodie Bénard,Marie-Claude Boily,Marie-Claude Boily,Stephen Sy,Catherine Regan,Adam Keane,Adam Keane,Michael Caruana,Michael Caruana,Diep N. Nguyen,Diep N. Nguyen,Megan Smith,Megan Smith,Jean-François Laprise,Mark Jit,Mark Jit,Mark Jit,Michel Alary,Freddie Bray,Elena Fidarova,Fayad Elsheikh,Paul Bloem,Nathalie Broutet,Raymond Hutubessy +36 more
TL;DR: It is suggested that high HPV vaccination coverage of girls can lead to cervical cancer elimination in most LMICs by the end of the century, and elimination could occur between 2059 and 2102, depending on the threshold and region.